The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai will expand its research training program in skin biology with support from a five-year, $1.3 million T32 grant from the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
The research training program in Systems Skin Biology will take a multidisciplinary approach in teaching scientists to holistically understand human physiology, health, and disease. As a recognized leader in research for skin biology and skin diseases, Mount Sinai will also become an incubator for future biomedical leaders in the field as a result of this program.
Traditional skin biology often focuses on the most obvious cells of the skin, keratinocytes, which form the structure of the epidermis and are essential for skin repair. The Systems Skin Biology program will take an interconnected approach based on the premise that neurons, immune cells, and blood vessels are just as much skin biology as traditional skin cells. Mount Sinai researchers have previously discovered new treatments for itch by studying the intersection of nerves and immune cells, and believe future studies through the Systems Skin Biology program will uncover understandings about wound repair, cancer, hair loss, vitiligo, and acne.
Science and medicine are rapidly evolving, and thus, the training itself must adapt, said co-Principal Investigator Brian S. Kim, MD, MTR, FAAD, Vice Chair of Research and Director of the Mark Lebwohl Center for Neuroinflammation and Sensation at Icahn Mount Sinai. This T32 program is truly unique in that it moves away from focusing on only one discipline, but embraces interdisciplinary training across two traditionally disparate fieldssuch as neuroscience and immunologyby using the skin and associated diseases as a model paradigm.
Dr. Kim, a renowned physician-researcher in chronic itch and inflammatory skin conditions, said the grant (number 1T32AR082315-01) will initially fund two predoctoral fellows or physician-scientists and two postdoctoral fellows or physician-scientists. It will facilitate the training of students toward PhD and/or MD/PhD degrees in intersectional skin biology, as well as training scientists and clinicians with advanced degrees to become independently funded principal investigators. In addition to dermatology, the research training program in Systems Skin Biology will include expertise drawn from across the Health System, including skin biology, immunology, neuroscience, epithelial biology, translational medicine, and stem cell biology.
This training grant will be particularly helpful for pre- and postdoctoral fellows and dermatology residents interested in bringing a new angle and new approaches to skin research, said co-Principal Investigator Sarah E. Millar, PhD, Director of the Black Family Stem Cell Institute and Senior Associate Dean for Basic Research at Icahn Mount Sinai. After training in diverse labs across Mount Sinais campus, they will be able to apply those new skills to uncover novel mechanisms in skin biology and diseases.
This T32 program is one of many steps toward our Department becoming the epicenter of innovation and a world leader in dermatology, as well as in training the future leaders and key opinion thought leaders in dermatology, said Emma Guttman-Yassky, MD, PhD, Waldman Professor of Dermatology and Immunology at Icahn Mount Sinai and Chair of Dermatology at the Mount Sinai Health System. In addition to bringing recognition of the breadth of institutional excellence in cutaneous diseases and skin biology at Mount Sinai, this training program will have an indelible impact on the future of dermatology and dermatology research for decades to come.
Mount Sinai continues to be a leader in the field of skin biology throughout New York City and the tri-state region. In 2021, the Health System established a Skin Biology and Diseases Resource-based Centerthen one of only six nationwide supported by a NIAMS grant. The Center uses technical innovations, high-end infrastructure, and computing power available at Mount Sinai to advance and support skin research; it also embeds experts in gene editing, genomics, and bioinformatics within skin research labs to break down interdisciplinary communication barriers.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.
Ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 44 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, and gastrointestinal and liver diseases.
Icahn Mount Sinai offers highly competitive MD, PhD, and masters degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. In addition, more than 535 postdoctoral research fellows are in training within the Health System.
A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinais technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into health care products and services that benefit the public.
Icahn Mount Sinais commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the Schools programs. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.
The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinais location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
Originally posted here:
Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand ... - Mount Sinai
- Memorial Health System is re-opening of Department of Dermatology - Parkersburg News - October 26th, 2024 [October 26th, 2024]
- Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology... - October 26th, 2024 [October 26th, 2024]
- What To Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD - MD Magazine - October 26th, 2024 [October 26th, 2024]
- Navigating Complexities and Unmet Needs of Chronic Hand Eczema - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Schweiger Dermatology Group Expands in Florida with the Acquisition of ClearlyDerm, Adding 5 New Offices in South Florida - PR Newswire - October 26th, 2024 [October 26th, 2024]
- Leo Pharma tells doctors to 'Talk to the Hand' in new dermatology campaign - FiercePharma - October 26th, 2024 [October 26th, 2024]
- Dermatology Partners To Expand Maryland Presence With New Westminster Clinic, Hosts Free Skin Cancer Screenings For Veterans On November 11 - citybiz - October 26th, 2024 [October 26th, 2024]
- Peter Lio, MD: The Latest Perspectives on Pathophysiology and Treatment of Eczema - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell... - October 26th, 2024 [October 26th, 2024]
- Dermatology Patients Taking Biologics are Wary About Most Vaccines - Medpage Today - October 13th, 2024 [October 13th, 2024]
- Safe and Effective: Upadacitinib Shows Promise in PN Treatment - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- SPONSORED: First Care, Heartland Dermatology team up again for free health screening event - Hays Post - October 13th, 2024 [October 13th, 2024]
- Global Dermatology Drugs Market to Worth Over US$ 50.42 Billion By 2032 | Astute Analytica - GlobeNewswire - October 13th, 2024 [October 13th, 2024]
- Working to Improve Mental Health - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- Bimekizumab Demonstrates Safety and Efficacy in Elderly Patients with Psoriasis - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- Analyzing Efficacy and Safety in Diverse Clinical Trials: New Roflumilast Data - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- UCB at EADV 2024: committed to advancing care in immuno-dermatology - UCB - October 2nd, 2024 [October 2nd, 2024]
- Positive Results Reported in Roflumilast 0.15% for AD Across Diverse Populations - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- Dermatology Excimer Laser Market is expected to Double Its Size - openPR - October 2nd, 2024 [October 2nd, 2024]
- InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and... - October 2nd, 2024 [October 2nd, 2024]
- Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD - MD Magazine - September 23rd, 2024 [September 23rd, 2024]
- Organon Moves Into Branded Dermatology With Dermavant Takeout - Scrip - September 23rd, 2024 [September 23rd, 2024]
- Dermatology Research Team Investigating the Most Common Disease Youve Never Heard About - University of Miami - September 23rd, 2024 [September 23rd, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress - Business Wire - September 23rd, 2024 [September 23rd, 2024]
- Hensin Tsao, MD, PhD: TIL Therapy and Neoadjuvant Treatment for Pigmented Lesions - Dermatology Times - September 23rd, 2024 [September 23rd, 2024]
- Derm In The News: September 8-14 - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Nearly half of FDA-authorized AI tools may be ineffective - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Dermatology Diagnostic Devices And Therapeutics Market - openPR - September 15th, 2024 [September 15th, 2024]
- Industry Deep Dive: Dermatology Devices Market Size, Share, and Growth Forecast with Emerging Trends through 2032 - openPR - September 15th, 2024 [September 15th, 2024]
- SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Veterinary Dermatology Drugs Market Global Latest Trends and Insights 2024 to 2031 - openPR - September 15th, 2024 [September 15th, 2024]
- Championing equity in skin of color dermatology - Fierce healthcare - August 5th, 2024 [August 5th, 2024]
- Derm In The News: July 28-August 3 - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Interview Intersection: Expert Interviews From July 2024 - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Generation Z, Millennials Exhibit Similar Subjective Perception of Atopic Dermatitis Disease Severity - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Long-Term Efficacy and Insights from POETYK PSO-1 Studies: Implications for Psoriasis Treatment - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Laurel Dermatology emphasizes the importance of sunscreen - WDAM - July 26th, 2024 [July 26th, 2024]
- The Interplay Between Sleep Disorders and Dermatology - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Latex Gloves and the Americans With Disabilities Act - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Advanced Practice Providers Share Insights at the 2024 Society for Pediatric Dermatology Annual Meeting - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Almiralls H1 2024 Results: Almirall Delivers Strong Performance in the First Half of 2024, Achieving Net Sales Growth of 6.7% Driven by Its European... - July 26th, 2024 [July 26th, 2024]
- Arcutis Submits sNDA for Roflumilast Foam to FDA for Scalp and Body Psoriasis - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Appier and SkinX Thailand Partner to Revolutionise Dermatology Services with AI - SME Magazine - July 26th, 2024 [July 26th, 2024]
- Diagnostic dermatology market to be valued at $43.4b by 2034 - Healthcare Asia - July 26th, 2024 [July 26th, 2024]
- FDNY Partners with American Academy of Dermatology to Provide Free Skin Cancer Checks - nyc.gov - June 1st, 2024 [June 1st, 2024]
- Day 1 Recap: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- Dermatology's Rosanne Paul discusses safety of foot peels - The Daily | Case Western Reserve University - June 1st, 2024 [June 1st, 2024]
- Sneak Peek: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- New Dermatology Center to Open at The Grand Resort's Med Spa - businessjournaldaily.com - June 1st, 2024 [June 1st, 2024]
- Dermatology Care of Alabama goes the extra mile to give the best care - Hoover Sun - June 1st, 2024 [June 1st, 2024]
- QUIZ RECAP: Treatment and Management of Skin Cancer - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- What to Know About Peptides, the Retinol Alternative Dermatologists Love | SELF - Self - June 1st, 2024 [June 1st, 2024]
- Reviewing Common and Prevalent Dermatoses in AAPI Patients - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- Dermatologists Advise Against Taking Bite Of Facial Cream - The Onion - June 1st, 2024 [June 1st, 2024]
- Prescription Dermatology Therapeutics Market Drivers And Restraints Identified Through SWOT Analysis 2030 - openPR - June 1st, 2024 [June 1st, 2024]
- Derm In The News: May 19-25 - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- What Gen Z Should Know About Sunscreen to Help Protect From Skin Cancer - The New York Times - June 1st, 2024 [June 1st, 2024]
- American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables - Newswise - April 15th, 2024 [April 15th, 2024]
- Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Atopic Dermatitis (Eczema): 5 Top Self-Care Tips - Everyday Health - April 15th, 2024 [April 15th, 2024]
- Derm In The News: April 7-13 - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Generative models improve fairness of medical classifiers under distribution shifts - Nature.com - April 15th, 2024 [April 15th, 2024]
- A 30-Year-Old White Female Presented With a 4-Month History of Scaly, Erythematous Patches and Plaques on Her ... - MDedge - April 15th, 2024 [April 15th, 2024]
- 9 Best Baby Eczema Creams of 2024 to Soothe Delicate Skin, According to Dermatologists - Allure - April 15th, 2024 [April 15th, 2024]
- QUIZ: Test Your Knowledge of Rosacea Etiology, Types, and Triggers - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Empowering Patients: Effective Dermatologic Treatment Selection for Hand and Feet AD - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- How To Treat Strawberry Legs, According To Dermatologists - Women's Health - April 15th, 2024 [April 15th, 2024]
- Rosacea Awareness Month: Resources to Share With Your Patients - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Derm In The News: March 31-April 6 - Dermatology Times - April 7th, 2024 [April 7th, 2024]
- Dr. Hillary Johnson-Jahangir of Forefront Dermatology Designated as a Candela Center of Excellence - PR Newswire - April 7th, 2024 [April 7th, 2024]
- How to Boost Your Immune System While Living With Psoriasis - Everyday Health - April 7th, 2024 [April 7th, 2024]
- Im a Harvard-trained dermatologist Ive followed 3 anti-aging rules for years, Im still a fan of a drug... - The US Sun - April 7th, 2024 [April 7th, 2024]
- Cosmetic Procedures for Psoriasis: Are They Safe? - Everyday Health - April 7th, 2024 [April 7th, 2024]
- FDA Approves Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum - Dermatology Times - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - The Mountaineer - January 8th, 2024 [January 8th, 2024]
- Dermatology treatments can become an expensive ongoing cost. - Islander News.com - January 8th, 2024 [January 8th, 2024]